Navigation Links
NeoStem, Inc. Comments on Recent Selling Pressure
Date:5/28/2008

NEW YORK, May 28 /PRNewswire/ -- Responding to the decline in NeoStem, Inc.'s (Amex: NBS) market capitalization during the past four trading days, Robin Smith, CEO, NeoStem said, "We know of no business development at the Company that would lead to the sudden decline in our share price."

Dr. Smith continued, "As announced on May 21, 2008, we received a private placement financing in a total amount of $900,000, which includes a strategic investment from the New England Cryogenic Center, Inc., one of the largest full-service cryogenic laboratories in the world and participation by management. These funds will be instrumental in executing on our plans to educate potential clientele about our services, especially in the Northeast." The private placement was of units with each unit priced at $1.20 and consisting of one share of common stock and a warrant to buy one share of common stock at $1.75 per share.

In addition, on May 27, 2008, NeoStem announced that an agreement had been signed with the University of Louisville Hospital's James Graham Brown Cancer Center to become a NeoStem collection center for adult stem cells. NeoStem has now signed its first agreement with a hospital to become a stem cell collection center and it believes this unique corporate and academic relationship will assist in propelling the adult stem cell field forward.

"We remain extremely excited by the growth prospects for NeoStem and are pleased to see the recent article written by Alan Boyle, Science Editor, MSNBC, entitled "Stem Cell Banks Could Pay Medical Dividends." The link reference is http://www.msnbc.msn.com/id/24797415/

About NeoStem, Inc.

NeoStem has a growing nationwide network of adult stem cell collection centers, enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's periodic filings with the Securities and Exchange Commission. Further, the Company cautions that its very small embryonic-like (VSEL) stem cell technology is in early stages of research and the reference to Alan Boyle's article is only intended to show the interest in stem cell banking generally and not to imply anything about the Company's products and services. The Company's further development is highly dependent on future medical developments and market acceptance which is outside its control.

Contact:

NeoStem, Inc.

Robin Smith, Chief Executive Officer

T: 212-584-4180

E: rsmith@neostem.com

http://www.neostem.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lyme Lies: Allen Steeres horrifying comments regarding Lyme disease in last weeks commencement address
2. RNC RESPONSE TO OBAMA COMMENTS ON MEDICAL MARIJUANA LAWS
3. InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results
4. Xmark Comments on Genaera Cost-Saving Plan
5. Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
6. FRC Action Praises John McCains Pro-Life Comments
7. JAMA editor-in-chief comments on Pfizer lawsuit
8. Vital Images Comments on CMS Decision to Allow Local Coverage for Cardiac CT Angiography
9. Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
10. MGT Comments on American Cancer Societys Decision to Endorse CT Colonography
11. URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology: